Effect of HMGB1 on human hepatoma cell line-HepG2 proliferation / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
; (12): 451-457, 2010.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-814430
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE@#To investigate the effect of high mobility group box-1 protein (HMGB1) on the proliferative activity of human hepatoma cell line HepG2 and its potential regulating mechanism.@*METHODS@#The cultured HepG2 cells were treated with recombinant HMGB1 (0, 10, 50, and 100 ng/mL, respectively) for 24 h. Cell proliferation was observed by MTT analysis. Western blot and reverse transcriptase-polymerase chain reaction were used to detect the expression of proliferating cell nuclear antigen (PCNA) and cyclin D1 protein and mRNA, respectively.@*RESULTS@#Compared with the control group, HMGB1 at 10, 50, and 100 ng/mL obviously increased HepG2 cells proliferation, cyclin D1 and PCNA protein and mRNA expression after the treatment for 24 h, respectively (P<0.05). Anti-HMGB1 significantly inhibited the proliferation and cyclin D1 and PCNA mRNA and protein expression of HMGB1 on HepG2 cells (P<0.05).@*CONCLUSION@#Proliferation of HMGB1 on HepG2 cells may be associated with increasing cyclin D1 and PCNA expression. Anti-HMGB1 may have a therapeutic effect on hepatocellular carcinoma.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Farmacologia
/
Proteínas Recombinantes
/
RNA Mensageiro
/
Antígeno Nuclear de Célula em Proliferação
/
Ciclina D1
/
Reação em Cadeia da Polimerase Via Transcriptase Reversa
/
Proteína HMGB1
/
Proliferação de Células
/
Células Hep G2
/
Genética
Limite:
Humanos
Idioma:
Chinês
Revista:
Journal of Central South University(Medical Sciences)
Ano de publicação:
2010
Tipo de documento:
Artigo